A Phase 1-2 dose-escalation and expansion study of ST316 in subjects with selected advanced unresectable and metastatic solid tumors
Clinical Trial Grant
Awarded By
Sapience Therapeutics Inc.
Start Date
August 28, 2023
End Date
May 31, 2028
Awarded By
Sapience Therapeutics Inc.
Start Date
August 28, 2023
End Date
May 31, 2028